Assessment the Effect of Fomoterol and Budesonide Combination in Moderate and Severe Asthmatic Patients Admitted to Ahvaz Imam Hospital-Iran

New combinations of drugs are used for asthma control, which aim to achieve lack of symptoms and increase pulmonary function with the least amount of drug administration. In this study, the clinical recovery of pulmonary function in asthmatic patients before and after two weeks of treatment with a combination of fomoterol and budesonide compared. Subjects and

This study was carried out on 58 newly diagnosed moderate and severe asthmatic patients referred to Ahvaz Imam Hospital during the first six months of the 2012. Physical examination and FVC, FEV1 and PEF variables were assessed using spirometry. After two weeks treatment with a combination of fomoterol (320µg) and budesonide (9µg) turbohaler the patients were re-evaluated. SPSS analysis software and ANOVA (t-test) methods were used for data analysis.

The mean FEV1 before treatment was 2.92±1.2 which increased to 3.1±0.78 after treatment ((P<0.05). The FVC before treatment was 3.51±1.4 also increased significantly after treatment 3.87± 0.98 (P<0.05). On the other hand, PEF percentage for pretreatment was 1.8 ± 4.50 %, which significantly increased to 4.98±0.6% after treatment (P <0.05).

The use of the combination of formetrol plus budesonide for the treatment of moderate and severe asthma was found to be useful in clinical and can achieve satisfactory control of moderate and severe asthma.